Tranexamic acid-based prediction model for blood transfusion in traumatic brain injury: A retrospective case-control study | [Pakistan Journal of Pharmaceutical Sciences • 2025]

Author(s):

1. Ren Hu: Department of Blood Transfusion, Affiliated Hospital of Xuzhou Medical University,,China

2. Xiu-cun Wang: Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical University,,China

3. Zhen Yan: Department of Blood Transfusion, Affiliated Hospital of Xuzhou Medical University,,China

Abstract:

Blood transfusion planning in traumatic brain injury (TBI) is ideal and pharmacotherapy such as tranexamic acid (TXA) may influence transfusion requirement. Within this retrospective, single-center case-control study, 259 TBI patients who were admitted from January 2022 to December 2024 were randomly allocated into training (70%) and validation (30%) datasets. Demographic, clinical, laboratory, surgical and pharmacologic variables-like TXA-were evaluated using univariable and multivariable logistic regression for independent predictors of transfusion. Surgery, tracheal intubation, longer hospital stay, lower hemoglobin and TXA administration were independent predictors of transfusion. The TXA nomogram had high discrimination (AUC 0.94 training; 0.93 validation), good calibration and clinical utility as demonstrated by decision curve analysis. Higher TXA use in transfused patients is likely due to confounding by indication, as patients were more ill and more likely to receive TXA. The inclusion of TXA in predictive models enhances personalized risk prediction of transfusion, but the model remains hypothesis-generating and requires external multicenter verification before being used clinically. This study is supportive of the development of pragmatic, pharmacology-driven tools for early risk stratification and precision transfusion planning in TBI.

Page(s): 2392-2400

DOI: 10.36721/PJPS.2025.38.6.REG.15256.1

Published: Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 6, Year: 2025

Keywords:

Blood transfusion , tranexamic acid , Traumatic brain injury , Risk prediction

References:

[1] Abdallah AA,Sallam AA,Arafa MS .2021 .Topical tranexamic acid in total knee arthroplasty: Does it augment the effect of the intravenous administration in patients with moderate-to-high risk of bleeding? A randomized clinical trial. J. Knee Surg., 34(14) : 1570-8.

[2] Ahmadzia HK,Luban NL,Li S,Guo D,Miszta A,Gobburu JV,Berger JS,James AH,Wolberg AS,van den Anker J .2021 .Optimal use of intravenous tranexamic acid for hemorrhage prevention in pregnant women. Am. J. Obstet. Gynecol., 225(1) : 85-e1.

[3] Affan A,Zurada JM,Inanc T JM .2021 .Adaptive individualized modeling from limited clinical data for precise anemia management. IEEE Access, 9 : 119466-75.

[4] Anderson TN,Farrell DH,Rowell SE .2021 .Fibrinolysis in traumatic brain injury: Diagnosis, management and clinical considerations. Semin, 47(5) : 527-37.

[5] Bossers SM,Loer SA,Bloemers FW,Den Hartog D,Van Lieshout EM,Hoogerwerf N,Absalom J,Peerdeman AR,SM AR .2021 .Association between prehospital tranexamic acid administration and outcomes of severe traumatic brain injury. JAMA Neurol, 78(3) : 338-45.

[6] Cao MM,Zhang YW,Sheng RW,Gao W,Kang QR,Gao YC,Qiu XD,Rui YF .2023 .General anesthesia versus regional anesthesia in the elderly patients undergoing hip fracture surgeries: A systematic review and meta-analysis of randomized clinical trials. World J. Surg., 47(6) : 1444-56.

[7] Colomina Soler MJ,Contreras L,Guilabert P,Koo Gómez M,Méndez E,Sabate Pes A .2022 .Clinical use of tranexamic acid: Evidences and controversies. , 72(6) : 795-812.

[8] Dong W,Tang Y,Zhou Y,Li J,Wu C,Liu Y,Yan Y,Zhao Z,J Z .2025 .Application and research progress of tranexamic acid in the perioperative period of posterior lumbar interbody fusion. Front. Med, 12 : 1612281.

[9] Eyth A,Borngaesser F,Rudolph MI,Paschold BS,Ramishvili T,Kaiser L,Tam CW,Wongtangman K,Eikermann G,Garg S,Karasick MH .2025 .Development and validation of a risk model to predict intraoperative blood transfusion. JAMA Netw. Open, 8(4) : e255522.

[10] Florez-Perdomo WA,Garcia-Ballestas E,Martinez-Perez R,Agrawal A,Deora H,Joaquim AF,QuinonesOssa GA AF .2023 .Hemoglobin levels as a transfusion criterion in moderate to severe traumatic brain injury: A systematic review and meta-analysis. Br. J. Neurosurg., 37(6) : 1473-9.

[11] Gernsheimer TB,Brown SP,Triulzi DJ,Key NS,El Kassar N,Herren H,Poston JN,Boyiadzis M,Reeves BN,Selukar S,Pagano MB .2022 .Prophylactic tranexamic acid in patients with hematologic malignancy: A placebo-controlled, randomized clinical trial. Blood, 140(11) : 1254-62.

[12] Guo Y,Guo XM,Li RL,Zhao K,Bao QJ,Yang JC,Zhang Q,Yang MF .2021 .Tranexamic acid for acute spontaneous intracerebral hemorrhage: A meta-analysis of randomized controlled trials. Front, 12 : 761185.

[13] Guyette FX,Brown JB,Zenati MS,Early-Young BJ,Adams PW,Eastridge BJ,Nirula R,Vercruysse GA,O'Keeffe T,Joseph B,Alarcon LH B .2021 .Tranexamic acid during prehospital transport in patients at risk for hemorrhage after injury: A double-blind, placebo-controlled, randomized clinical trial. JAMA Surg, 156(1) : 11-20.

[14] Ha EJ .2024 .Optimizing RBC transfusion strategies in traumatic brain injury: Insights on early resuscitation and cerebral oxygenation. Korean J. Neurotrauma, 20(3) : 137.

[15] Hanley C,Callum J,Jerath A,Anaesth J. .2021 .Tranexamic acid and trauma coagulopathy: Where are we now? Br. , 126(1) : 12-7.

[16] Hassoun-Kheir N,Hussein K,Abboud Z,Raderman Y,Abu-Hanna L,Darawshe A,Bolotin G .2020 .Risk factors for ventilator-associated pneumonia following cardiac surgery. J. Hosp. Infect., 105(3) : 546-51.

[17] Hinson HE,Radabaugh HL,Li N,Fukuda T,Pollock J,Schreiber M,Rowell S,Ferguson AR .2024 .Predicting progression of intracranial hemorrhage in the prehospital TXA for TBI trial. J. Neurotrauma, 41 : 2349-61.

[18] Hollingworth M,Woodhouse LJ,Law ZK,Ali A,Krishnan K,Dineen RA,Christensen H,England TJ,Roffe C,Werring D,Peters N D .2024 .The effect of tranexamic acid on neurosurgical intervention in spontaneous intracerebral hematoma: Data from 121 surgically treated participants from the tranexamic acid in intraCerebral hemorrhage-2 randomized controlled trial. Neurosurgery, 95(3) : 605-16.

[19] Kataria S,Juneja D,Singh O D .2025 .Redefining haemostasis: Role of rotational thromboelastometry in critical care settings. World J. Crit. Care Med, 14(2) : 102521.

[20] Lee S,Kim M,Kwon SM,Kwon MY,Kim CH,Son NH,Kim JH .2025 .Relationship between tranexamic acid use and safety in patients with acute brain injury: A systematic review and meta-analysis of mortality and thromboembolic events. CNS Drugs, 39(7) : 637-650.

[21] Lee SM,Lee G,Kim TK,Le T,Hao J,Jung YM,Park CW,Park JS,Jun JK,Lee HC,Kim D HC .2022 .Development and validation of a prediction model for need for massive transfusion during surgery using intraoperative hemodynamic monitoring data. JAMA Netw. Open, 5(12) : e2246637.

[22] Li M,Jiang W,Lin J,Du H,Shan J,Qin L J .2025 .Development and evaluation of a dynamic nomogram model for intraoperative blood transfusion decisionmaking. Front. Med, 12 : 1566325.

[23] Li YY,Yu TS,Ho CN,Lai YC,Yew M,Yu CH,Hung KC .2025 .Thromboembolic safety and clinical benefits of tranexamic acid beyond hemostasis in post-COVID19 patients undergoing major arthroplasty: A STROBEcompliant retrospective study. Med, 104(36) : e44317.

[24] Li Z,You M,Long C,Bi R,Xu H,He Q,Hu B .2020 .Hematoma expansion in intracerebral hemorrhage: an update on prediction and treatment. , 11 : 702.

[25] Lo HC,Hsu SC,Soong RS,Huang SK .2024 .Unraveling postoperative bleeding dynamics in laparoscopic Roux-en-Y gastric bypass: Insights from a single-center tranexamic acid study. Obes. Surg., 34(8) : 3012-20.

[26] Meer MM,Mumtaz M,Farrukh Z,Ahmed B,Meer M .2024 .Efficacy and safety of tranexamic acid in traumatic brain injury: A systematic review and metaanalysis of randomized controlled trials. Cureus, 16(11) : e73781.

[27] Montgomery EY,Barrie U,Kenfack YJ,Edukugho D,Caruso JP,Rail B,Hicks WH,Oduguwa E,Pernik MN,Tao J,Mofor P .2022 .Transfusion guidelines in traumatic brain injury: A systematic review and metaanalysis of the currently available evidence. Neurotrauma Rep, 3(1) : 554-68.

[28] Nakae R,Murai Y,Morita A,Yokobori S A .2022 .Coagulopathy and traumatic brain injury: Overview of new diagnostic and therapeutic strategies. Neurol. Med, 62(6) : 261-9.

[29] Napolitano LM .2021 .Hemostatic defects in massive transfusion: an update and treatment recommendations. Expert Rev. Hematol., 14(2) : 219-39.

[30] Prudovsky I,Kacer D,Zucco VV,Palmeri M,Falank C,Kramer R,Carter D,Rappold J .2022 .Tranexamic acid: beyond antifibrinolysis. Transfusion, 62 : S301-12.

[31] Rakhit S,Nordness MF,Lombardo SR,Cook M,Smith L,Patel MB .2021 .Management and challenges of severe traumatic brain injury. Semin. Respir. Crit. Care Med, 42(1) : 127-44.

[32] Vacas S Rathmell C .2025 .Transfusion thresholds in patients with neurological injury: Balancing oxygen delivery and risk. J. Neurosurg. Anesthesiol., 37(3) : 265-70.

[33] Rowell SE,Meier EN,McKnight B,Kannas D,May S,Sheehan K,Bulger EM,Idris AH,Christenson J,Morrison LJ,Frascone RJ .2020 .Effect of out-ofhospital tranexamic acid vs placebo on 6-month functional neurologic outcomes in patients with moderate or severe traumatic brain injury. JAMA, 324(10) : 961-74.

[34] Russell R,Bauer DF,Goobie SM,Haas T,Nellis ME,Nishijima DK,Vogel AM,Lacroix J .2022 .Plasma and platelet transfusion strategies in critically ill children following severe trauma, traumatic brain injury and/or intracranial hemorrhage: From the transfusion and anemia expertise initiative-control/avoidance of bleeding. Pediatr. Crit. Care Med, 23(Suppl 1) : e14-24.

[35] Sigmon J,Crowley KL,Groth CM .2023 .Therapeutic review: The role of tranexamic acid in management of traumatic brain injury, nontraumatic intracranial hemorrhage and aneurysmal subarachnoid hemorrhage. Am. J. Health-Syst. Pharm., 80(18) : 1213-22.

[36] Stitt G,Spinella PC,Bochicchio GV,Roberts I,Downes KJ,Zuppa AF .2024 .Population pharmacokinetic modelling and simulation of tranexamic acid in adult trauma patients. Br. J. Clin. Pharmacol, 90(8) : 1932-41.

[37] Taccone FS,Bittencourt CR,Møller K,Lormans P,Quintana-Díaz M,Caricato A,Ferreira MA,Badenes R,Kurtz P,Søndergaard CB,Colpaert K CB .2024 .Restrictive vs liberal transfusion strategy in patients with acute brain injury: The TRAIN randomized clinical trial. JAMA, 332(19) : 1623-33.

[38] Turgeon AF,Fergusson DA,Clayton L,Patton MP,Neveu X,Walsh TS,Docherty A,Malbouisson LM,Pili-Floury S,English SW S .2024 .Liberal or restrictive transfusion strategy in patients with traumatic brain injury. N. Engl. J. Med, 391(8) : 722-35.

[39] Wang D,Lu Y,Sun M,Huang X,Du X,Jiao Z,Sun F,Xie F F .2022 .Pneumonia after cardiovascular surgery: Incidence, risk factors and interventions. Front. Cardiovasc. Med, 9 : 911878.

[40] Wang L,Du Y,Huang N,Yin N,Du J,Yang J,Jiang L,Mao Y .2024 .Clinical characteristics and anaesthetic management of severe scoliosis patients with spinal muscular atrophy: Case series. , 86(2) : 643-9.

[41] Wu J,Moheimani H,Li S,Kar UK,Bonaroti J,Miller RS,Daley BJ,Harbrecht BG,Claridge JA,Gruen DS .2022 .High dimensional multiomics reveals unique characteristics of early plasma administration in polytrauma patients with TBI. Ann. Surg., 276(4) : 673-83.

[42] Yokobori S,Yatabe T,Kondo Y,Kinoshita K Y .2020 .Efficacy and safety of tranexamic acid administration in traumatic brain injury patients: A systematic review and meta-analysis. J. Intensive Care, 8(1) : 46.

[43] Yoon JY,Park JH,Kim YS,Shin SJ,Yoo JC,Oh JH .2020 .Effect of tranexamic acid on blood loss after reverse total shoulder arthroplasty according to the administration method: A prospective, multicenter, randomized, controlled study. J. Shoulder Elbow Surg., 29(6) : 1087-95.

[44] Yuan X,Zhang S,Wan J,Chen C,Wang P,Fan S,Liu Y,Yang J,Hou J,You Q,Li X .2024 .Efficacy of restrictive versus liberal transfusion strategies in patients with traumatic brain injury: A systematic review and meta-analysis of randomized controlled trials. Ann. Intensive Care, 14(1) : 177.

[45] Zhang M and Liu T .2024 .Efficacy and safety of tranexamic acid in acute traumatic brain injury: a metaanalysis of randomized controlled trials. Am. J. Emerg. Med, 80 : 35-43.

Citations

Downloads

Views